Lilly reports third-quarter 2026 financial results, raises full-year guidance and highlights regulatory progress across the portfolio – Eli Lilly
Lilly reports third-quarter 2026 financial results, raises full-year guidance and highlights regulatory progress across the portfolio Eli LillyEli Lilly blows past estimates, hikes sales outlook on resilient Zepbound and Mounjaro demand CNBCEli Lilly lifts revenue outlook on weight-loss drug sales, trims profit view on deal charges ReutersLilly Raises Sales Guidance, Widening Its Lead in Obesity Market BloombergLilly: Q3 Earnings Snapshot Yahoo Finance
সূত্র: মূল সংবাদসূত্র